We are live on
!
Find out more
TCIM
TIAA CREF Investment Management Portfolio holdings
AUM
$141B
1-Year Est. Return
14.18%
This Fund
S&P 500
This Quarter
Est. Return
+1.19%
1 Year Est. Return
+14.18%
3 Year Est. Return
+70.08%
5 Year Est. Return
+108.37%
10 Year Est. Return
–
AUM
$141B
AUM Growth
-$2.7B
(-1.9%)
Cap. Flow
-$2.99B
Cap. Flow
% of AUM
-2.12%
Top 10 Holdings %
Top 10 Hldgs %
13.67%
Holding
3,275
New
158
Increased
1,529
Reduced
1,512
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$245M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Biogen
BIIB
|
+$189M |
| 4 |
AT&T
T
|
+$187M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$339M |
| 2 |
Gilead Sciences
GILD
|
+$226M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$177M |
| 4 |
Tesla
TSLA
|
+$162M |
| 5 |
SLB Ltd
SLB
|
+$159M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 14.87% |
| 3 | Financials | 13.87% |
| 4 | Consumer Discretionary | 10.67% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
BioCryst Pharmaceuticals
BCRX
$2.4B
| $5.24M | ﹤0.01% |
350,731
-2,307
| -0.7% | -$26.2K |
|
1652
1-800-Flowers.com
FLWS
$258M
| $5.23M | ﹤0.01% |
500,344
+273,683
| +121% | +$2.83M |
|
1653
WesBanco
WSBC
$4B
| $5.22M | ﹤0.01% |
153,557
+12,480
| +9% | +$406K |
|
1654
Hanover Insurance
THG
$7.98B
| $5.22M | ﹤0.01% |
70,530
-69,575
| -50% | -$5M |
|
|
GPT
1655
DELISTED
Gramercy Property Trust
GPT
| $5.21M | ﹤0.01% |
74,264
+17,962
| +32% | +$1.44M |
|
1656
Icahn Enterprises
IEP
$5.3B
| $5.2M | ﹤0.01% |
60,000
| – | – |
|
|
BPFH
1657
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $5.2M | ﹤0.01% |
387,700
+30,947
| +9% | +$396K |
|
|
ONIT
1658
Onity Group
ONIT
$332M
| $5.18M | ﹤0.01% |
33,829
+4,831
| +17% | +$703K |
|
1659
Argan
AGX
$8.37B
| $5.17M | ﹤0.01% |
128,188
+44,583
| +53% | +$1.6M |
|
|
MNTA
1660
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $5.17M | ﹤0.01% |
226,478
+58,019
| +34% | +$1.16M |
|
|
XHR
1661
Xenia Hotels & Resorts
XHR
$1.79B
| $5.16M | ﹤0.01% |
+237,523
| New | +$5.41M |
|
|
TCF
1662
DELISTED
TCF Financial Corporation Common Stock
TCF
| $5.16M | ﹤0.01% |
156,175
+30,216
| +24% | +$953K |
|
1663
Compañía de Minas Buenaventura
BVN
$8.67B
| $5.16M | ﹤0.01% |
496,924
+54,480
| +12% | +$597K |
|
1664
Green Plains
GPRE
$1.03B
| $5.14M | ﹤0.01% |
186,752
+53,390
| +40% | +$1.64M |
|
|
PKY
1665
DELISTED
Parkway, Inc.
PKY
| $5.14M | ﹤0.01% |
294,795
-28,513
| -9% | -$489K |
|
|
BMR
1666
DELISTED
BIOMED REALTY TRUST INC
BMR
| $5.14M | ﹤0.01% |
265,821
+15,873
| +6% | +$329K |
|
|
SHLM
1667
DELISTED
Schulman (A.) Inc
SHLM
| $5.14M | ﹤0.01% |
117,576
-1,616
| -1% | -$72K |
|
|
CIR
1668
DELISTED
CIRCOR International, Inc
CIR
| $5.14M | ﹤0.01% |
94,179
-1,580
| -2% | -$87.2K |
|
|
AVNS
1669
DELISTED
Avanos Medical
AVNS
| $5.13M | ﹤0.01% |
126,533
-81,067
| -39% | -$3.64M |
|
|
ALU
1670
DELISTED
Alcatel-Lucent
ALU
| $5.12M | ﹤0.01% |
1,413,022
-21,754,144
| -94% | -$83.5M |
|
|
MORE
1671
DELISTED
Monogram Residential Trust, Inc.
MORE
| $5.11M | ﹤0.01% |
+566,472
| New | +$5.38M |
|
1672
RingCentral
RNG
$5.28B
| $5.11M | ﹤0.01% |
276,229
+83,489
| +43% | +$1.45M |
|
1673
ICU Medical
ICUI
$4.61B
| $5.09M | ﹤0.01% |
53,264
-3,331
| -6% | -$311K |
|
|
BFX
1674
DELISTED
BowFlex Inc.
BFX
| $5.09M | ﹤0.01% |
236,746
+20,441
| +9% | +$406K |
|
1675
Universal Electronics
UEIC
$61.3M
| $5.09M | ﹤0.01% |
102,147
-2,440
| -2% | -$131K |
|
Similar funds
TA
O
HFS
SBAM
BB
SA
WF
BCPEM
TIAA CREF Investment Management's Q2 2015 Portfolio in Review
As of Q2 2015, TIAA CREF Investment Management held 3,275 positions worth $141B, down 1.9% from $144B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
TIAA CREF Investment Management's Q2 2015 filing shows 158 new, 1,529 increased, 1,512 reduced and 51 closed positions. Its largest new stake was Univar Solutions Inc.: 3,464,152 shares worth $90.2M. The largest sale was Apple, an estimated $339M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- TIAA CREF Investment Management's largest Q2 2015 buy was Univar Solutions Inc.: 3,464,152 shares worth $90.2M.
- TIAA CREF Investment Management added most to Eli Lilly in Q2 2015, an estimated $245M increase.
- TIAA CREF Investment Management's biggest Q2 2015 reduction was Apple, cutting an estimated $339M.
- TIAA CREF Investment Management fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $150M.
- TIAA CREF Investment Management's ten largest holdings make up 14% of its $141B portfolio in Q2 2015.
- TIAA CREF Investment Management opened 158 new positions and closed 51 in Q2 2015.
- TIAA CREF Investment Management's portfolio value fell 1.9% quarter-over-quarter to $141B.
Based on TIAA CREF Investment Management's 13F filing for Q2 2015, filed 10 Aug 2015.